ESMO 2020

19–21 September 2020 | Virtual Meeting

The European Society for Medical Oncology (ESMO) 2020 was held virtually from 19–21 September. ESMO 2020 brought together leading experts from around the globe, who presented the latest cutting-edge advancements in the field of oncology.

View all videos

Managing comorbidities in lung cancer patients

Dirk De Ruysscher • 16 Oct 2020

Lung ART trial updates from ESMO 2020

Sanjay Popat • 2 Oct 2020

Breast cancer at ESMO 2020: CDK4/6 inhibitors and checkpoint inhibitors

Guy Jerusalem • 22 Sep 2020

PRS-343 in HER2-Positive Solid Tumors: A trial update

Geoffrey Ku • 24 Sep 2020

ESMO highlights: 705MO study in GU cancer

Pavlos Msaouel • 19 Sep 2020

PRS-343 in HER2-Positive Solid Tumors: A trial update

Geoffrey Ku • 24 Sep 2020

Sacituzumab govitecan in metastatic urothelial carcinoma: updates on the Phase II study

Yohann Loriot • 23 Sep 2020

Updates on the DANUBE, KEYNOTE-361 and JAVELIN Studies

Yohann Loriot • 23 Sep 2020

Treatment options for mUC following chemo-immunotherapy failure

Aris Bamias • 23 Nov 2020

IMvigor130: patient-reported outcomes by the addition of atezolizumab to PBC in mUC

Aris Bamias • 23 Nov 2020

QuEST1 clinical trial updates

Jason Redman • 23 Sep 2020

Updates in urological cancer presented at ESMO 2020

Ben Tran • 22 Sep 2020

Impact of sexual dimorphism in cancer healthcare

Anna D. Wagner • 16 Oct 2020

PRS-343 in HER2-Positive Solid Tumors: A trial update

Geoffrey Ku • 24 Sep 2020

Highlights from ESMO 2020 in gynecological cancers

Alexandra Leary • 24 Sep 2020

ENGOT-EN3-NSGO/PALEO: Letrozole-palbociclib combination for endometrial cancer

Mansoor Mirza • 22 Sep 2020